Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
2.200
-0.010 (-0.45%)
Oct 2, 2026, 11:23 AM EDT - Market open
Can-Fite BioPharma Employees
Can-Fite BioPharma had 5 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$81,000
Profits / Employee
-$1,910,600
Market Cap
6.50M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 5 | 0 | - |
| Dec 31, 2024 | 5 | -3 | -37.50% |
| Dec 31, 2023 | 8 | 0 | - |
| Dec 31, 2022 | 8 | 0 | - |
| Sep 30, 2022 | 8 | 0 | - |
| Dec 31, 2021 | 8 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| CollPlant Biotechnologies | 39 |
| Lunai Bioworks | 29 |
| Bolt Biotherapeutics | 23 |
| Imunon | 20 |
| Enveric Biosciences | 6 |
| Alzamend Neuro | 6 |
| Acurx Pharmaceuticals | 4 |
CANF News
- 7 days ago - Can-Fite BioPharma Registration statement: Registration filing - Filings
- 7 days ago - Can-Fite BioPharma Registration statement: Registration filing - Filings
- 23 days ago - Can-Fite: Publication Reports Improvement in Decompensated Cirrhosis with Namodenoson and Successful Bridging to Liver Transplantation - GlobeNewsWire
- 24 days ago - Can-Fite Reports Q2 2026 Financial Results and Ongoing Clinical Progress Highlighting Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study - GlobeNewsWire
- 24 days ago - Can-Fite BioPharma Earnings release: Q2 2026 - Filings
- 4 weeks ago - Can-Fite Enters Warrant Exercise Deal For $4 Mln, Shares To Be Issued At Discount; Stock Plunges - Nasdaq
- 4 weeks ago - CANF Looks 45.6% Undervalued on GF Value™ Despite Challenging Fundamentals - GuruFocus
- 4 weeks ago - Can-Fite Announces Exercise of Warrants for Approximately $4.0 Million in Gross Proceeds - GlobeNewsWire